Pub. Date : 2017 May
PMID : 28291381
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The SELIMETRY trial (EudraCT No 2015-002269-47) aims to investigate the role of the MEK inhibitor Selumetinib in resensitizing advanced iodine refractory differentiated thyroid cancer to radioiodine therapy. | Iodine-131 | mitogen-activated protein kinase kinase 7 | Homo sapiens |